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Abstract
India is ecologically vast and has close to a billion-population living at risk of malaria. 
Given the evidence-based present-day intervention tools and large-scale implementa-
tion, India has recorded declining trends in disease transmission from 2 million cases in 
2001 to close to a million cases in 2017 and embarked upon malaria elimination in keep-
ing with the Global Technical Strategy by 2030. India is malaria endemic, but transmis-
sion intensities varied across its landscape with just few States of the east, central and 
northeast contributing bulk (80%) of total positive cases. Plasmodium falciparum and P. 
vivax are the predominant infections of which there has been steady increase in propor-
tions of the former for constituting >60% of total cases what was 50:50 in 2001, a phe-
nomenon attributed to emerging drug resistance. With the rolling out of the available 
intervention tools, malaria elimination is foreseeable yet there are multiple challenges 
which must be addressed to overcome the constraints. We strongly advocate continued 
disease surveillance and monitoring, universal coverage and intensification of core-
interventions for prevention and treatment prioritizing high-risk States, strengthen-
ing cross-border collaborations for information sharing and coordinated activities, and 
above all sustained allocation of resources, creating the enabling environment to end 
malaria transmission.
Keywords: malaria elimination, epidemiology, Plasmodium falciparum, drug-resistance, 
mosquito vectors, insecticide resistance, Southeast Asia
1. Introduction
The advent of new intervention tools including Noble prize-winning discovery of Artemis-
inin by Tu Youyou for treatment of malaria combined with large-scale  implementation of 
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 insecticide-treated netting materials for vector containment has once again renewed the 
optimism of malaria elimination globally. Malaria map is shrinking with more than 35 
countries certified to be malaria free, and another 21 countries that are likely to reach zero 
indigenous transmission (categorized as E-2020) are set to be declared malaria free by 2020 
[1, 2]. Many more countries are moving forward from control to elimination. The Global 
Technical Strategy for Malaria 2016–2030 envisages: (i) to reduce global malaria mortality 
rates and case incidence by at least 90% compared to 2015 levels, (ii) to make at least 35 
countries malaria free that reported cases in 2015 and (iii) preventing re-establishment in 
countries with no indigenous transmission [3]. Among member countries of the Southeast 
Asia Region of WHO (SEAR), Maldives and Sri Lanka have already been certified malaria 
free in 2015 and 2016, respectively, and Bhutan is targeting elimination in the foreseeable 
future. In the past decade, India has registered drastic decrease in cases and have formu-
lated National Framework for Malaria Elimination (2016–2030) in close alignment with the 
Global Technical Strategy for Malaria, Roll Back Malaria Action (RBM), Investment to defeat 
Malaria (AIM) and the Asia Pacific Leaders Malaria Alliance (APLMA) for shared experi-
ences and coordinated action to eliminate malaria (zero indigenous cases) throughout the 
country by 2030 [4]. The said task is set to be accomplished in phased manner with the fol-
lowing objectives: (i) eliminate malaria in all 26 low-to-moderate transmission States/Union 
Territories (UTs) by 2022, (ii) reduce the case incidence to <1 per 1000 population by 2024 in 
all States/UTs, (iii) interrupt indigenous transmission throughout the country by 2027 and 
(iv) prevent re-establishment of local transmission and maintain malaria-free status by 2030 
and beyond.
India is historically endemic for both Plasmodium vivax and P. falciparum malaria and has 
history of successes and resurgences [5, 6]. Malaria was on the verge of elimination post-
independence in 1960s with 0.1 million cases and no death, yet it reared its ugly head again 
in 1970s with record number of six million cases and many deaths attributed to technical 
and operational constraints. Transmission is largely seasonal corresponding to rainy season 
with record of focal disease outbreaks characterized by high rise in cases and attributable 
deaths. In 2017, India reported 0.84 million cases, the highest disease burden in SEAR mem-
ber countries of WHO [4, 7]. Almost all Indian States and UTs are reporting cases, which 
can be broadly stratified into three different categories based on Annual Parasite Incidence 
(API) per 1000 population, that is, Category—I (total of 15 States/UTs including districts 
with API < 1) that are targeted for elimination phase, Category—II (total of 11 States/UTs 
with API < 1 with one or more districts reporting > 1 API) marked for pre-elimination phase 
and Category—III (total of 10 States/UTs with > 1 API) targeted for intensified control 
operations. With the rolling out of the present day evidence-based intervention tools, dis-
ease transmission is on the steady decline presenting window of opportunity to accelerate 
toward universal coverage for malaria prevention and treatment. India is a huge country 
(population 1.3 billion) with majority populous (80%) living at risk of malaria. The task is 
enormous and daunting. Given the political commitment and National Framework devel-
oped by the National Vector Borne Disease Control Programme (NVBDCP) of Government 
of India, malaria elimination is foreseeable, yet there are multiple challenges which must 
Towards Malaria Elimination - A Leap Forward258
be addressed to overcome the constraints. In this chapter, we attempt to enumerate some of 
these issues helping strengthen healthcare services in combating malaria menace enabling 
elimination by due date.
2. Malaria transmission in India: current distribution and parasite 
formula
Malaria transmission is heterogenous across Indian landscape for its diverse ecology and 
multiplicity of disease vectors [8]. Malaria is a serious public health concern and almost 
all 36 States/UTs are consistently contributing cases, but transmission intensities varied 
ranging from low-to-moderate (Table 1). Among these, north-eastern, eastern and central 
Indian States consistently contributed 80% of the total disease burden having concentration 
of cases (API > 10) associated with large forest cover, ethnic tribes, poverty and high rainfall 
(Figure 1). These included States of Odisha (formerly Orissa) and Jharkhand (eastern India), 
Chhattisgarh and Madhya Pradesh (central India) and Meghalaya and Tripura (northeast 
India), which together contributed >65% of P. falciparum cases. Approximately a billion 
population of India resides in malaria endemic areas, however, 80% of malaria cases are 
reported by just 20% of the population living in the forest-fringe, tribal and foothills hard-
to-reach areas of the country little aware of disease prevention and access to treatment [9]. 
These areas are prone to periodic disease outbreaks resulting in flare up of cases and 
attributable mortality accounting for inter-annual variation in reported morbidity. From 
the epidemiological data for the past 17 years (2001–2017), disease transmission trends are 
observed to be declining from two million cases in 2001 to close to a million cases in 2017 
(Figure 2). However, consequent to the introduction of artemisinin-based combination ther-
apy (ACT) beginning 2010 coupled with insecticide-treated netting materials (ITNs); there 
has been drastic decrease in cases and deaths. P. falciparum and P. vivax are the predominant 
infections of which there has been steady increase in proportions of the former parasite spe-
cies presently constituting >60% of total cases what was 50:50 in 2001. Every single death 
was attributed to P. falciparum, majority of which were contributed by high-risk States of 
north-eastern, eastern and central India (Figure 3). The distribution of P. malariae is patchy, 
recorded in indigenous tribes of eastern, north-eastern and central India [10–12], but trans-
mission of P. ovale except for few sporadic reports could not be clearly ascertained [13–15]. 
There exists no record of P. knowlesi malaria in India making inroads in other Southeast 
Asian countries [16].
The reported cases and deaths; however, are far from acccurate for disease surveillance that 
can be best described as fragmented and there is no system in place to capture data from 
private and public sectors alike, least the asymptomatic cases [17]; WHO estimates are much 
higher to the tune of >10 million cases and deaths manifold [1]. Nevertheless, the presented 
data showed disease transmisison trends in relation to existing interventions, and monitoring 
and evaluation in practice.
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No State/Union 
Territories
2014 2015 2016 2017
Total 
malaria 
cases
Plasmodium 
falciparum 
cases
Deaths Total 
malaria 
cases
Plasmodium 
falciparum 
cases
Deaths Total 
malaria 
cases
Plasmodium 
falciparum 
cases
Deaths Total 
malaria 
cases
Plasmodium 
falciparum 
cases
Deaths
1 Andhra 
Pradesh
21,077 15,511 0 25,042 18,709 0 23,613 17,443 0 16,913 11,944 0
2 Arunachal 
Pradesh
6082 2338 9 5088 1714 7 3144 911 2 1538 487 0
3 Assam 14,540 11,210 11 15,557 11,675 4 7826 5686 6 5473 4131 0
4 Bihar 2043 699 0 4006 1286 1 5205 895 0 3175 356 2
5 Chhattisgarh 128,993 108,874 53 144,886 123,839 21 148,220 121,503 61 141,310 115,153 0
6 Goa 824 42 0 651 75 1 742 130 0 653 75 2
7 Gujarat 41,608 6253 16 41,566 7232 7 44,783 6298 6 37,801 3502 2
8 Haryana 4485 45 1 9308 726 3 7866 552 0 6887 904 0
9 Himachal 
Pradesh
102 1 0 60 1 0 121 19 0 95 9 0
10 Jammu & 
Kashmir
291 21 0 216 8 0 242 11 0 226 0 0
11 Jharkhand 103,735 46,448 8 104,800 54,993 6 141,414 83,232 15 92,770 42,047 1
12 Karnataka 14,794 1329 2 12,445 1598 0 11,078 1746 0 6529 1118 0
13 Kerala 1751 305 6 1549 400 4 1547 419 2 1194 317 2
14 Madhya 
Pradesh
96,879 41,638 26 100,597 39,125 24 69,106 22,304 3 46,176 15,554 3
15 Maharashtra 53,385 25,770 68 56,603 31,139 59 23,983 7815 26 18,133 5929 19
16 Manipur 145 72 0 216 119 0 122 58 0 80 22 0
17 Meghalaya 39,168 37,149 73 48,603 43,828 79 35,147 31,867 45 16,433 14,974 11
18 Mizoram 23,145 21,083 31 28,593 24,602 21 7583 5907 9 5710 4978 0
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No State/Union 
Territories
2014 2015 2016 2017
Total 
malaria 
cases
Plasmodium 
falciparum 
cases
Deaths Total 
malaria 
cases
Plasmodium 
falciparum 
cases
Deaths Total 
malaria 
cases
Plasmodium 
falciparum 
cases
Deaths Total 
malaria 
cases
Plasmodium 
falciparum 
cases
Deaths
19 Nagaland 1936 647 2 1527 532 3 828 316 0 394 188 1
20 Orissa 395,035 342,280 89 436,850 369,533 80 449,697 389,332 77 352,140 297,554 25
21 Punjab 1036 14 0 596 13 0 693 8 0 808 12 0
22 Rajasthan 15,118 603 4 11,796 662 3 12,741 1031 5 6837 377 0
23 Sikkim 35 18 0 27 11 0 15 5 0 12 3 0
24 Tamil Nadu 8729 339 0 5587 355 0 4341 242 0 5449 197 0
25 Telangana 5189 4602 0 10,951 10,206 4 3512 2617 1 2688 2170 0
26 Tripura 51,240 49,653 96 32,525 30,074 21 10,546 9545 14 7040 6572 6
27 Uttarakhand 1171 89 0 1466 73 0 961 47 0 532 14 0
28 Uttar Pradesh 41,612 326 0 42,767 371 0 39,238 158 0 32,345 159 0
29 West Bengal 26,484 4981 66 24,208 5775 34 35,236 5928 59 30,008 4632 29
30 A.N. Islands 557 109 0 409 77 0 485 140 0 404 67 0
31 Chandigarh 114 0 0 152 1 1 157 0 0 114 1 0
32 D & N Haveli 669 90 1 418 46 0 375 30 0 297 16 0
33 Daman & Diu 56 4 0 84 18 0 48 7 0 37 4 0
34 Delhi 98 0 0 54 0 0 31 0 0 577 2 0
35 Lakshadweep 0 0 0 4 0 0 2 0 0 1 0 0
36 Puducherry 79 3 0 54 5 1 76 11 0 59 13 0
All India total 1,102,205 722,546 562 1,169,261 778,821 384 1,090,724 716,213 331 840,838 533,481 103
*Source: Ref. [7].
Table 1. Malaria-attributable morbidity and mortality in different States and Union Territories (UTs) of India during 2014–2017*.
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3. Multiple disease vectors and insecticide resistance
India holds the distinction in malaria epidemiological research for Noble prize-winning discovery 
that malaria is transmitted by mosquitoes by Sir Ronald Ross on the day of August 20, 1897, and 
for monumental work on faunistic surveys dating back to 1930s [18]. Of the 58 anopheline spe-
cies recorded in India [19], six major vector taxa are implicated in malaria transmission, including 
Anopheles culicifacies s.l., An. fluviatilis s.l., An. minimus s.l., An. dirus s.l., An. sundaicus s.l. and An. 
stephensi [20]. All of these, except An. stephensi, are species complexes among which members 
Figure 1. Malaria stratification by Annual Parasite Incidence (API) in Indian States for data based on 2014. API 10 
corresponds to 10 confirmed cases per 1000 population. Source: Ref. [4].
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were repeatedly incriminated as vectors evidenced by detection of live sporozoites in salivary 
glands across range of their distribution [21, 22]. With added tools of molecular taxonomy; how-
ever, there have been significant advances in understanding sibling-species composition of these 
taxa [23–25], distribution and their bionomics helping target species-specific control interventions 
in place and time (Table 2). Among these, An. culicifacies is the most widespread and extensively 
Figure 2. Malaria-attributable morbidity and mortality in India during 2001–2017. Malaria positive cases denote 
confirmed diagnosis by presence of malarial parasite in finger-prick blood-smears; Pf cases denote positivity for 
Plasmodium falciparum; death cases are attributed to confirmed falciparum malarial infection. Source: Ref. [7].
Figure 3. Distribution of malaria-attributed deaths in different geoepidemiological regions of India for data based on 
2014–2017. NE refers to group of seven sister States of northeast India including Arunachal Pradesh, Assam, Meghalaya, 
Manipur, Mizoram, Nagaland and Tripura; Central States include Madhya Pradesh and Chhattisgarh; Eastern States 
include Bihar, Jharkhand, Odisha (formerly Orissa) and West Bengal; Western States include Maharashtra, Goa, Gujarat and 
Rajasthan. In the remaining Indian States and Union Territories, death cases were few and far (not shown). Source: Ref. [7].
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Anopheles 
species/
taxa
Sibling 
species 
prevalent in 
India (total 
identified)
Diagnostic 
cytotaxonomic/
molecular tools
Breeding habitats Feeding behavior 
(peak biting 
activity)
Resting 
habitats
Sporozoite 
infectivity 
(%)
Insecticide 
susceptibility 
status
Distribution range
An. 
culicifacies 
s.l.
A,B,C,D and 
E (5)
Fixed paracentric 
inversions, PCR 
based sequencing of 
28S-D3 domain; ITS2-
PCR-RFLP; rDNA 
ITS2
Rain water 
collections, riverine 
pools, rice fields, 
seepage water, 
streams, borrow 
pits, irrigation 
channels
Predominantly 
zoophilic except 
‘E’ (A and B: 
22:00–23:00; C and 
D: 18:00–21:00; no 
data for E)
Human-
dwellings 
indoors and 
cattle sheds
Incriminated 
(0.3–20)
Resistant 
to DDT, 
malathion and 
pyrethroids
Throughout rural 
India
An. 
fluviatilis 
s.l.
S, T, U and 
Form ‘V’ (4)
Fixed paracentric 
inversions; PCR 
based sequencing 
of rDNA ITS2; 28S 
rDNA-D3
Seepage water 
foothill streams, 
irrigation channels, 
river ecology, 
shallow wells
Sibling species 
‘S’—highly 
anthropophilic 
(20:00–24:00); 
‘T’—zoophilic
S—human 
dwellings 
indoors; T—
cattle sheds
Incriminated Highly 
susceptible to 
all residual 
insecticides
Throughout India 
except north-eastern 
States
An. 
minimus s.l.
An. minimus 
s.s. (3)
rDNA ITS2; 28S 
rDNA-D3
Perennial foothill 
seepage water 
streams
Highly 
anthropophilic 
(01:00—04:00)
Human-
dwellings 
indoors
Incriminated 
(3.0)
Highly 
susceptible to 
all residual 
insecticides
North-eastern of 
Arunachala Pradesh, 
Assam, Meghalaya, 
Manipur, Mizoram, 
Nagaland, Tripura, 
and Eastern State of 
Odisha
An. dirus s.l. An. baimaii 
(8)
Karyotypic 
studies, polytene 
chromosome 
analysis, gene-
enzyme variation, 
DNA probes, rDNA 
ITS2; SCAR-PCR
Jungle water pools, 
Elephant foot-prints
Highly 
anthropophilic 
(21:00—24:00)
Exophilic Incriminated 
(1.9)
Highly 
susceptible to 
all residual 
insecticides
North-eastern of 
Arunachala Pradesh, 
Assam, Meghalaya, 
Manipur, Mizoram, 
Nagaland, Tripura
An. 
sundaicus 
s.l.
An. sundaicus 
cytotype 
D (4)
Mitochondrial DNA 
cytochrome oxidase 
1 and cytochrome-b; 
rDNA ITS2; 28S 
rDNA-D3
Brackish water 
including swamps, 
salt water lagoons, 
creeks as well as 
fresh water
Predominantly 
zoophilic except 
indoor resting 
populations 
(21:00—04:00)
Both 
indoors and 
outdoors
Incriminated Highly 
susceptible to 
all residual 
insecticides
Andaman & Nicobar 
Islands
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Anopheles 
species/
taxa
Sibling 
species 
prevalent in 
India (total 
identified)
Diagnostic 
cytotaxonomic/
molecular tools
Breeding habitats Feeding behavior 
(peak biting 
activity)
Resting 
habitats
Sporozoite 
infectivity 
(%)
Insecticide 
susceptibility 
status
Distribution range
An. 
stephensi
Not 
applicable
Domestic 
containers, building 
construction sites, 
overhead water 
storage tanks, 
underground 
cement tanks, desert 
coolers
Predominantly 
anthropophilic 
(22:00—24:00)
Endophilic Incriminated Resistant to 
DDT and 
Malathion
Urban metropolitan 
cities of India
*Source: Refs. [20, 23–25]; rDNA, ribosomal DNA; SCAR, sequence characterized amplified region; ITS2, internal transcribed spacer 2; PCR, polymerase chain reaction.
Table 2. Bionomics, distribution and sibling-species composition of the dominant mosquito vector taxa of human malaria in India*.
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studied for its sibling species composition (A, B, C, D and E), distribution range, seasonal preva-
lence, larval ecology, feeding and breeding behavior and disease transmission relationships [26]. 
Species E is the most efficient malaria vector of all having predilection for human host, while 
species B is a poor vector for its zoophilic characteristics. The other three species (A, C and D) 
are responsible for local transmission in areas of their predominance [27]. This taxon is the most 
abundant rural vector in plains of mainland India generating about 65% of cases annually and 
held responsible for focal disease outbreaks associated with build-up of vector density. It is 
regarded as highly adaptive species for its diverse breeding habitats and invading new territories 
in degraded forests of north-eastern India evidenced by records of rising density and incrimina-
tion [28–30]. Its control has become a formidable challenge for having grown multi-resistant vir-
tually to all available insecticides including pyrethroids opening new vistas for research on newer 
interventions that are sustainable, cost-effective and community-based [31–33].
An. fluviatilis complex is just as widespread and have overlapping distribution with An. culici-
facies throughout India [20]. Among its sibling species, that is, S, T, U and form ‘V’; it is spe-
cies S which is highly anthropophilic and responsible for maintaining hyperendemic malaria 
predominantly in foothills of eastern India contributing ~15% of reported cases [34]. It shares 
similar bionomical characteristics with yet another efficient malaria vector species An. minimus 
s.s for breeding in foothill seepage water streams and resting indoors in human dwellings [35]. 
Both are highly susceptible to residual insecticides. An. minimus instead is the most predomi-
nant vector species of north-eastern States of India and has long history of disappearance and 
re-appearance stymying the control authorities. It is reckoned as the most efficient vector spe-
cies for its high anthropophily (human blood index > 90%) and fulminating focal disease out-
breaks taking heavy toll of human lives [36]. It is a perennial species and widely incriminated 
practically all months of the year with average sporozoite infection rate of 3% [37]. This species 
exhibits high behavioral plasticity for avoiding sprayed surfaces for weeks and establishing 
extra-domiciliary transmission in response to indoor residual spraying (IRS). While this spe-
cies has staged comeback in eastern State of Odisha after lapse of 45 years [38], the populations 
of An. minimus once again are reported diminishing in erstwhile domains of its distribution in 
northeast India corroborated by evidence of reducing disease transmission [35]. It presents an 
unprecedented opportunity to strengthen interventions to keep populations of this species at 
bay helping achieve malaria elimination specific to the region at sub-national level.
Within the An. dirus complex, An. baimaii is the only vector occurring in India with a wide preva-
lence in the north-eastern States and has been recorded in high densities and incriminated in 
range of its distribution [39]. It is just as efficient vector species with strong predilection for human 
host but distinct from An. minimus for its breeding and resting characteristics [40, 41]. It is a for-
est dweller affecting forest-fringe human settlements along inter-country and inter-state border 
areas causing devastating disease outbreaks often in conjunction with An. minimus; together they 
contribute 10% of reported cases in the country [42]. Its control has become difficult for peak bit-
ing activity during second quartile (21:00–00:00) of the night as well as exophilic resting behav-
ior avoiding sprayed surfaces. Its populations along with that of An. minimus are also depleting 
owing to deforestation and urbanization [29, 30]. However, niche thus vacated by both these 
species is accessed by An. culicifacies s.l. and has established foothold erstwhile recorded in low-
density [26, 28]. Among sibling species of the An. sundaicus complex, cytotype species D has been 
 characterized with a regional importance presently confined to Andaman and Nicobar Islands 
[43]. It is a brackish water species, largely zoophilic and susceptible to residual insecticides.
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An. stephensi is the only urban vector species breeding in domestic containers and often asso-
ciated with tropical aggregation of labor at construction sites in metropolitan cities [44]. The 
species is resistant to multiple insecticides and its control focused on ‘source reduction’ to 
contain urban malaria. Due to continued urbanization and associated labor migration, urban 
malaria is viewed as a growing menace contributing about 10% of cases in the country [5–7].
Besides these dominant vectors, member species of An. maculatus s.l., An. annularis s.l. and 
An. subpictus s.l. are also implicated; however, these species are considered of lesser significance 
for being predominantly zoophilic [45, 46]. Vector control is an integral part of the malaria 
control strategy in India and huge investment is made annually to contain build-up of disease 
vectors averting epidemic malaria. What is tantamount to vector control is the entomological 
surveillance for developing malaria-risk maps, judicious application of insecticides, monitor-
ing insecticide-resistance and residual efficacy, universal coverage for population at risk and 
continued research for newer interventions, which are community-based and sustainable. We 
strongly believe that judicious mix of technologies that are situation-specific and doable would 
help save operational costs in resource-poor settings. The country is in dire need of skilled ento-
mologist/taxonomists (an expertise that is getting scarce) to meet the human resource require-
ments for control of malaria, and other vector-borne diseases, as well as vector surveillance 
post-elimination to prevent re-establishment of local transmission in malaria-free territories.
4. Drug-resistant malaria
Of the two prevalent malaria parasite species, the rising proportions of P. falciparum is of 
grave concern for presently constituting >60% of total reported cases in the country [5, 7]. 
Rising trends of P. falciparum are largely attributed to fast emerging drug-resistance over 
space and time in parallel with phenomenon happening in countries of the Greater Mekong 
Subregion (GMS) of Southeast Asia [47]. Historically, chloroquine (CQ) was the most com-
monly used drug for treatment ever since inception of the control program in 1953 for its 
efficacy and affordability. It had become obsolete since its first report of treatment failure in 
Assam (northeast India) way back in 1973 [48]. Subsequently, drug-resistant foci had multi-
plied for which northeast is considered corridor for spread to rest of peninsular India result-
ing in steady rise in proportions of P. falciparum what was 13% in 1978 to 65% in present day 
malaria [49]. Northeast India shares wide border with Myanmar contiguous with GMS coun-
tries which is porous for cross-border migration, facilitating entry of drug-resistant strains 
enroute to the rest of India and beyond. Malaria transmission along this border is intense 
vectored by An. minimus and An. baimaii (the two most efficient vector species), and healthcare 
access is inadequate resulting in indiscriminate and sub-optimal doses inter-alia, poor vector 
control, illiteracy and treatment-seeking behavior; all contributing to propagation and spread 
of drug-resistant malaria strains [50]. Chloroquine therapy was subsequently upgraded to 
sulfadoxine-pyrimethamine (SP) in 2004 as first-line treatment in selected districts report-
ing CQ-resistant malaria [51]. The therapeutic efficacy of SP was short lived resulting in 
substantial rise in cases in the following years [52]. It was in 1990s that the development of 
 artemisinin-derivatives raised new hopes for treatment of drug-resistant malaria for its fast 
acting schizontocidal properties. Initially, artemisinin was used as monotherapy for treatment 
of severe and complicated clinical malaria, discontinued in 2009 due to high recrudescence 
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rate and risk of resistance for being commonly prescribed medicine by private practitioners 
and public sector alike [53]. In 2010, the program adopted ACT by combining it with SP, that 
is, artesunate + SP (AS + SP) for treatment of every single case of P. falciparum malaria in high-
risk districts [54]. Mass scale introduction of this combination did result in appreciable trans-
mission reduction in endemic communities formerly intractable. It continues to be in practice 
throughout India except in the northeast region where it has been replaced by yet another 
combination therapy, that is, artemether + lumefantrine (AL) in 2013 due to declining efficacy 
of AS + SP combination drug [55]. The emergence of artemisinin resistance in Southeast Asia 
[56]; however, is a matter of grave concern for its movement westwards to India for having 
it detected in Myanmar close to the Indian border in northeast [57]. Genomic studies have 
already detected mutations in the ‘kelch 13’ propeller region (Pfk 13) linked to artemisinin 
resistance in north-eastern States, but to lesser frequency [58]. It is of utmost importance to 
periodically monitor the therapeutic efficacy of drug-regimen in force for radical cure and 
keep vigil on circulation of counterfeit drugs. The cost of spread of artemisinin-resistant 
malaria would be colossal, threatening the control and elimination efforts.
5. Plasmodium vivax malaria: the neglected parasite
The Southeast Asian countries contribute most of the vivax cases (58%) in the World of which 
India is the largest contributor [1]. Historically, much of the control efforts continue to be 
focused on control of falciparum malaria due to its associated severity and critical illness; 
the vivax malaria remained a neglected parasite [59]. Paradoxically, control of falciparum 
malaria is rather measurable in relation to interventions due to development of gametocytae-
mia 9–10 days post primary infection; instead the formation of gametocytes in vivax malaria 
is concurrent within few days of initial infection even before the patient seeks treatment per-
mitting uninterrupted transmission. This biological characteristic of vivax malaria along with 
intrinsic ability of formation of latent hibernating ‘hypnozoites’ has made control efforts a 
difficult proposition. Nevertheless, the control of vivax malaria is gaining eminence in the 
context of malaria elimination across the continents [60].
The magnitude of vivax malaria is huge but grossly underestimated throughout India and 
continues to be neglected [61]. The transmission and distribution of vivax malaria varied 
across Indian States/UTs, but large concentrations of cases are occurring in urban metropoli-
tan cities [7]. Although it remains highly susceptible to CQ therapy [62–66], its elimination is 
one difficult issue owing to latent stage ‘hypnozoites’ in the liver causing relapses amount-
ing to extended morbidity over months/years. The only available anti-relapse drug ‘prima-
quine (PQ)’ does not guarantee radical cure much due to extended therapy over days coupled 
with poor compliance resulting in repeated episodes [67–69]. In addition, the administra-
tion of PQ is associated with several issues including contraindication in special groups, that 
is, infants, pregnant or lactating mothers, and inborn glucose-6-phosphate dehydrogenase 
(G6PD)  deficiency syndromes due to associated hemolytic anemia; these population groups 
are excluded from primaquine therapy. There exists no diagnostics for detection of G6PD at 
point-of-care in the present surveillance system except few laboratories procedure for which 
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it is time consuming and impractical in field conditions where the problem exists. Further, 
given the available technologies, the detection of latent hypnozoites and sub-patent parasit-
emia is presently not built in the disease surveillance.
The primary attack of vivax malaria is invariably associated with acute paroxysm present-
ing classical symptoms but treatable and rarely fatal [70–72]; although few sporadic cases of 
CQ-resistant cases have been reported in India and several other countries [73]. There is acute 
need of alternative 8-aminoquinolines, which are safe and universally applicable for radical 
cure across all population groups preventing relapses. As of today, we stand ill equipped to 
tackle this stubborn parasite calling for renewed attack both on parasite and disease vectors 
in reducing parasite reservoir which is likely to persist for long.
6. Asymptomatic malaria
India is historically endemic for malaria with record of devastating epidemics in the pre-DDT 
era and varied population groups have been subject to repeated attacks of malarial bouts, 
resulting in acquired immunity and consequent build-up of asymptomatic sub-patent para-
sitemia in the endemic communities, serving as infectious reservoir for continued transmis-
sion. In India, the surveillance program is aimed at taking blood-smears from those who are 
either febrile (active surveillance) or presenting themselves (passive surveillance) for malaria 
diagnosis or treatment. There is no built-in mechanism to detect asymptomatic cases or even 
low-density/sub-patent parasitemia in the endemic communities. These infections may go 
undetected with conventional diagnostic techniques leaving them untreated, except for mass-
blood surveys/mass-drug administrations that are conducted only to contain epidemics. 
Asymptomatic malaria is more abundant than assumed and have been reported in different 
endemic States of India; however, the extent and distribution vary corresponding to transmis-
sion intensities [74–77]. Asymptomatic parasitemia is often associated with gametocyte car-
riage and may persist infectious throughout the year to mosquito vectors. These gametocytes 
are unable to cause clinical symptoms of malaria, rather ensure the uninterrupted transmis-
sion of malaria in the presence of efficient vectors. Asymptomatic cases remain undetected 
and not accounted for disease incidence amounting to gross underestimates.
Asymptomatic malaria in India remains entrenched in low-socioeconomic groupings liv-
ing in forest-fringe communities, particularly along inter-border areas (both inter-province 
and international borders), which are largely inaccessible (marred with insurgent activities), 
wherein healthcare infrastructure is meager or even non-existent. Such areas are ‘hot-spots’ 
for explosive disease outbreaks due to mixing/importation of drug-resistant strains associ-
ated with illegal migration more so in the northeast (the gateway to India) that shares wide 
international border with Myanmar, a member country of GMS (an epicenter of multi-drug 
resistant malaria) and other WHO SEAR countries. Asymptomatic malaria has been docu-
mented for both P. falciparum and P. vivax, yet the magnitude was much higher for the former 
parasite  species, more so in the winter months/dry-season, for example, in north-eastern State 
of Assam, for the high-risk districts surveyed, it varied from 7.1 to 31.1% in P. falciparum and 
0.6–6.1% in P. vivax [78]. But on average, 12.8% of afebrile subjects were positive for malaria 
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compared to 34.4% of those presenting with fever, and gametocyte carriage varied from 1.31 
to 2.16%. Major bottleneck in eliminating asymptomatic malaria parasite is the absence of stan-
dard guidelines and diagnostic procedures aimed at targeting asymptomatic carriers. Malaria 
control program in practice is largely limited to the qualitative detection of parasite mostly in 
febrile human hosts and subsequently treating with suitable drugs; however, no attention is 
given on follow up for quantification of malaria parasite till radical cure. Moreover, a univer-
sally accepted parasite level for categorizing a patient as asymptomatic is also not available. 
Quantification and treating asymptomatic malaria has become increasingly important and rel-
evant for disrupting transmission, requisite for achieving malaria elimination.
7. Cross-border malaria
India shares vast international border with Nepal, Bhutan and China to the North, Myanmar to 
the East, Bangladesh to the South and Pakistan to the West. Among these, borders with Myanmar 
and Bangladesh are of immediate concern for their high endemicity and common disease vec-
tors and ecology in the adjoining vicinity on either side of the border [79, 80]. These border areas 
are porous for cross-migration and have high forest cover inhabited by indigenous tribes living 
in impoverished conditions. These communities have poor access to healthcare services and are 
at high-risk to disease outbreaks attributed to drug-resistant strains originating from the GMS 
countries. These populations are largely marginalized and just as reluctant to seek treatment 
amounting to unattended parasite reservoirs. Border with Myanmar in particular is believed 
to be the corridor for entry of drug-resistant strains to northeast India for onward spread. The 
detection of artemisinin-resistant malaria in closer proximity to Indian border is seen as threat 
for making its way to India and beyond, similar to the path that was followed by CQ-resistant 
malaria [48, 49]. Cross-border malaria transmission from neighboring endemic countries can 
be daunting task and has regional implications jeopardizing the elimination efforts [81, 82]. 
For example, most cases reported in Bhutan (a country that is heading for malaria elimination), 
are imported from adjoining districts of Assam seeking treatment on other side of the border. 
Labor migration across borders engaged in developmental projects is unstoppable for want of 
livelihood and there exists every possibility of re-entry of malaria given the similar vectors and 
ecology. It is important to characterize the imported malaria strains enabling interventions well 
in place and time to prevent re-establishment of local transmission in declared malaria-free 
territories [83]. Inter-country coordinated efforts are deemed essential to maintain vigil and 
strengthening border-posts (entry/exit doors) with capacity to detect and treat malaria in the 
migrant/itinerant labor force at the earliest available opportunity. In keeping the same man-
date, India has joined hands with the Asia Pacific Malaria Elimination Network (APMEN) coun-
tries for shared experiences and coordinated action to achieve malaria elimination by 2030 [84]. 
Mitigating cross-border malaria should be accorded priority in context of malaria elimination.
8. Strengthening health systems
India has a well-structured vector-borne disease control program in place providing logistics 
support along with guidance and monitoring/evaluation services to malaria endemic States/
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UTs [4, 7]. Utilizing the evidence-based intervention tools and large-scale implementation, 
India has registered notable decline in cases and malaria-attributable deaths in the preceding 
few years (Figures 2 and 3). Among these, roll-out of ACT for treatment of every single case 
of P. falciparum malaria, rapid diagnostics test (RDT) kits for on-the-spot diagnosis and large-
scale provision of long-lasting insecticidal nets (LLINs) for vector control have resulted in 
rich dividends in reducing disease transmission in areas formerly intractable. Malaria threat 
is seen receding presenting an unprecedented opportunity for upscaling interventions in 
achieving universal coverage for populations at any risk making elimination an achievable 
target. However, the logistics requirement is huge for which increased funding from donors 
(both national and international agencies) and political commitment for sustained allocation 
of resources is of paramount importance for strengthening healthcare services reaching the 
outreach population groups for equitable access. A humble beginning has been made under 
National Health Mission (NHM), which envisages achievement of universal access to equi-
table, affordable and quality healthcare services both in urban and rural India [85]. Much 
needed disease surveillance in the country is further strengthened by Integrated Disease 
Surveillance Programme (IDSP) to detect early warning signals for impending disease out-
breaks instituting interventions to thwart the disease onslaught and spread [86]. Both these 
establishments have helped the program immensely in strengthening laboratory services 
averting disease outbreaks, as well as human resource development in providing training to 
State surveillance officers, rapid response teams and other medical and paramedical staffs. 
However, continuing education program is need of the hour for upgrading skills to keep 
pace with the changing technologies as well as to fill the void due to attrition of skilled work-
force. The induction of Accredited Social Health Activists (ASHA) have proven boon to the 
program ensuring door-to-door surveillance raising new levels of confidence in the poverty-
stricken communities. Host of Non-Governmental Organizations (NGOs)/media coverage 
have increased the reach of services in remote/inaccessible areas helping combating illness 
and saving lives. Collectively, communities today stand better informed and clearly benefit-
ted by increased awareness on disease prevention and control.
9. The way forward
In India, some States (Sikkim and Himachal Pradesh) and UTs (Lakshadweep, Daman & Diu 
and Puducherry) are already reporting <100 cases, while others recorded substantial decrease 
(>50%) in cases over past few years, for example, Assam and Karnataka (Table 1). Given the 
reducing transmission levels, malaria elimination at sub-national level is seemingly achiev-
able. However, the emergence of artemisinin-resistant malaria and possible spread, coupled 
with multiple insecticide resistance in disease vectors (Table 2), could reverse the gains for 
which disease surveillance, monitoring and evaluation should be the corner-stone activity. 
P. vivax and asymptomatic malaria continue to be unattended and should be accorded prior-
ity for reducing parasite reservoir in the endemic communities. Priority should be accorded 
for strengthening healthcare services in high-risk States of eastern, central and north-eastern 
States helping mitigate disease onslaught and deter entry and spread of drug-resistant strains 
in India. Inter-sectoral linkages with research establishments and medical colleges for devel-
oping innovative newer interventions (possibly vaccines), assessing therapeutic efficacy of 
Declining Transmission of Malaria in India: Accelerating Towards Elimination
http://dx.doi.org/10.5772/intechopen.77046
271
 antimalarials and upgradation of drug-treatment policy, human resource development and 
field-evaluation of newer technologies, including innovative vector control approaches, are 
vital before these are incorporated in the control program. Disease epidemiology is rapidly 
changing in the face of fast urbanization, deforestation and anomalous weather conditions 
opening new vistas, which must be watched for targeting interventions in place and time. 
Mosquito vectors are invading new territories, and adapting to altered ecology establishing 
outdoor transmission in response to strengthening insecticide interventions, which are largely 
based on indoor residual applications. We strongly advocate the judicious mix of technologies 
used in an integrated manner to overcome the challenges of outdoor transmission and grow-
ing insecticide resistance threatening the efficacy of present day intervention tools. There 
remains of scope of newer interventions in Indian geo-epidemiological conditions, namely, 
eave tubes, attractive sugar baits, nano-synthesized pesticides loaded with microbial- and 
plant-borne compounds, for trapping adult mosquito vectors and population reduction pres-
ently being put to field evaluation in African countries (Beier, personal communication). It is 
the high time to strengthen the entomological component at the State/Zonal level for moni-
toring vector densities and insecticide resistance targeting interventions averting impending 
disease outbreaks. Above all, educating communities and stakeholders on disease preven-
tion and control should be the guiding principle for increased compliance and harmonious 
action. Increased allocation of resources (both from State and Central assistance), for ensur-
ing universal coverage of interventions, should be given utmost priority in reducing parasite 
reservoir much below threshold density disrupting transmission [87]. It is time accelerating 
towards elimination and let there be no complacency at various echelons of operation for 
keeping disease at bay. Outside Africa, Southeast Asia is the largest contributor of cases and 
source of spread of drug-resistant malaria for which it is strongly advocated that larger share 
of global investments in this part of the World would go a long way in alleviating poverty 
and malaria. In summary, given the enormity of disease burden and myriad of issues, odds 
are all against, yet concerted efforts should be made in rendering malaria a thing of the past; 
together we can beat malaria.
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Towards Malaria Elimination - A Leap Forward272
AL artemether lumefantrine
API annual parasite incidence
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ASHA Accredited Social Health Activist
AS + SP artesunate + sulfadoxine-pyrimethamine
CQ chloroquine
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G6PD glucose-6-phosphate dehydrogenase
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IDSP Integrated Disease Surveillance Project
IRS indoor residual spray
ITN insecticide treated nets
ITS-2 internal transcribed spacer-2
LLIN long-lasting insecticidal nets
NGO Non-Governmental Organization
NHM National Health Mission
NVBDCP National Vector Borne Disease Control Programme
PCR polymerase chain reaction
Pf Plasmodium falciparum
Pfk 13 Plasmodium falciparum kelch 13
RBM roll back malaria
RDT rapid diagnostic test
r-DNA ribosomal-DNA
SCAR Sequence Characterized Amplified Region
SEAR WHO Southeast Asia Region
SP sulfadoxine-pyrimethamine
UT Union Territory
WHO World Health Organization
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